BPG is committed to discovery and dissemination of knowledge
Search Result
  • Sorted by:
1
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher 
World J Gastroenterol 22(44):9674-9693. Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9674
2
NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis 
Michael Wayne Fleischman, Matthew Budoff, Ifran Zeb, Dong Li, Temitope Foster 
World J Gastroenterol 20(17):4987-4993. Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.4987
3
NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients 
Sombat Treeprasertsuk, Einar Björnsson, Felicity Enders, Sompongse Suwanwalaikorn, Keith D Lindor 
World J Gastroenterol 19(8):1219-1229. Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1219
4
JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease 
Giovanni Tarantino, Armando Caputi 
World J Gastroenterol 17(33):3785-3794. Published online Sep 7, 2011. doi: 10.3748/wjg.v17.i33.3785
5
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence 
Shira Zelber-Sagi, Vlad Ratziu, Ran Oren 
World J Gastroenterol 17(29):3377-3389. Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3377
6
Pathogenesis and management issues for non-alcoholic fatty liver disease 
Marko Duvnjak, Ivan Lerotić, Neven Baršić, Vedran Tomašić, Lucija Virović Jukić, Vedran Velagić 
World J Gastroenterol 13(34):4539-4550. Published online Sep 14, 2007. doi: 10.3748/wjg.v13.i34.4539
7
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis 
Shiro Yokohama, Yoshihiko Tokusashi, Kimihide Nakamura, Yosui Tamaki, Satoshi Okamoto, Mituyoshi Okada, Kazunobu Aso, Takenao Hasegawa, Masaru Aoshima, Naoyuki Miyokawa, Masakazu Haneda, Masashi Yoneda 
World J Gastroenterol 12(2):322-326. Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.322
8
Changes in lipid metabolism in chronic hepatitis C 
Katalin Jármay, Gizella Karácsony, András Nagy, Zsuzsa Schaff 
World J Gastroenterol 11(41):6422-6428. Published online Nov 7, 2005. doi: 10.3748/wjg.v11.i41.6422
9
Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases 
N Assy, I Bekirov, Y Mejritsky, L Solomon, S Szvalb, O Hussein 
World J Gastroenterol 11(37):5834-5839. Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5834
10
Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: A case report 
Hiroki Oikawa, Chihaya Maesawa, Ryo Sato, Kanta Oikawa, Hiroyuki Yamada, Seizo Oriso, Sadahide Ono, Akiko Yashima-Abo, Koji Kotani, Kazuyuki Suzuki, Tomoyuki Masuda 
World J Gastroenterol 11(34):5394-5397. Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5394
11
Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH 
Stephan Laggai, Yvette Simon, Theo Ranssweiler, Alexandra K Kiemer, Sonja M Kessler 
World J Hepatol 5(10):558-567. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.558
12
姜黄素对NAFLD大鼠Visfatin、锌-α2糖蛋白的影响 
陈韵, 李珏宏, 李昌平, 钟晓琳, 康敏 
世界华人消化杂志 23(25):4005-4014. Published online Sep 8, 2015. doi: 10.11569/wcjd.v23.i25.4005
13
Visfatin、锌-α2糖蛋白在NAFLD发病机制中的研究进展 
陈韵, 李昌平 
世界华人消化杂志 23(1):58-63. Published online Jan 8, 2015. doi: 10.11569/wcjd.v23.i1.58
14
六味地黄丸对NAFLD大鼠肝脏组织SOD、MDA、TG和TC的影响及意义 
全晓红, 叶冬梅, 唐晓光 
世界华人消化杂志 22(6):819-824. Published online Feb 28, 2014. doi: 10.11569/wcjd.v22.i6.819
15
NAFLD家兔肠道菌群与肠黏膜Toll样受体4的关系 
王海昆, 杨涛, 姚萍 
世界华人消化杂志 21(35):3988-3993. Published online Dec 18, 2013. doi: 10.11569/wcjd.v21.i35.3988